Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Crypthecodinium is a genus of marine dinoflagellates, with Crypthecodinium cohnii being the primary species of industrial interest. This microorganism is notable for its ability to produce docosahexaenoic acid (DHA), a long-chain omega-3 fatty acid. DHA derived from Crypthecodinium oil is used as a vegetarian or vegan alternative to fish oil for dietary supplementation, particularly for those seeking plant-based sources of omega-3s.

Elevated triglycerides are a known risk factor for cardiovascular disease, and omega-3 fatty acids have been extensively studied for their triglyceride-lowering effects. While the majority of studies have focused on fish oil-derived eicosapentaenoic acid (EPA) and DHA, several clinical trials and meta-analyses indicate that DHA from microalgal sources, including Crypthecodinium, can also reduce serum triglyceride levels. For example, randomized controlled trials have shown that supplementation with algal DHA (often sourced from Crypthecodinium) leads to significant reductions in triglycerides compared to placebo. The effect size is generally in the range of a 10-25% reduction, depending on dose and baseline triglyceride levels.

Therefore, the use of Crypthecodinium-derived DHA for managing high triglycerides is supported by a moderate level of scientific evidence, primarily extrapolated from the broader body of research on omega-3 fatty acids, with some direct studies specifically on algal DHA sources. However, the evidence is less robust than that for fish oil, and not all studies distinguish between algal and fish-derived DHA.

More about Crypthecodinium
More about Triglycerides (high)

Other ingredients used for Triglycerides (high)

Other health conditions supported by Crypthecodinium

Products containing Crypthecodinium